Metabolomics: Taking Aim at Diabetic Kidney Failure | NIH Director's Blog
Metabolomics: Taking Aim at Diabetic Kidney Failure
National Institutes of Health (NIH) sent this bulletin at 01/23/2014 02:45 PM EST01/23/2014 09:00 AM EST
My own research laboratory has worked on the genetics of diabetes for two decades. One of my colleagues from those early days, Andrzej Krolewski, a physician-scientist at the Joslin Diabetes Center in Boston, wondered why about one-third of people with type 2 diabetes eventually develop kidney damage that progresses to end-stage renal disease (ESRD), but […]![](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_soz1z4yDTl6c4B2US1ybz0ITqIoOsX8aOuXLFKJ79vAqkskPxeE--YkFZB_FnRMhQLMY75Sk_pw1wvWQh2fE_uWP9azpaB5Ogizj3GrcQ_pvlA8EluymLCtbc7FWsCwMfzznhjW4mO7TMSH8SzkYN8FjroLOEaHISvkDiEDbd5LyZZPOZGJciBm1x8tv5tw1E5qGMlSM1P=s0-d)
No hay comentarios:
Publicar un comentario